The EIB and Utrecht-based AM-Pharma have signed a €24 million financing agreement. The funds will be used to accelerate the development of the clinical stage biopharmaceutical company’s recombinant alkaline phosphatase enzyme, which is used to treat acute kidney injury (AKI). The...
Tim Reid, CEO of UK Export Finance (UKEF) focuses on what’s changed, and what’s stayed the same against a backdrop of uncertainty for exporters. Defence, cyber, SMEs,...
TXF's editorial team sat down to discuss their best articles and insights of the year with few forward looking trends set to emerge in 2026.
New nuclear’s construction risk and development timelines have made it difficult to bank – until now. The RAB revenue model means that Sizewell C’s funding package includes an ECA-covered bank piece, but RAB may not provide value for money.
Tim Reid, CEO of UK Export Finance (UKEF) focuses on what’s changed, and what’s stayed the same against a backdrop of uncertainty for exporters. Defence, cyber, SMEs, concentration risk and EPC+F all come into focus. How can the ‘Venn diagram’ of overlap with MDBs be improved and how important is ‘less tied’ financing?
TXF's editorial team sat down to discuss their best articles and insights of the year with few forward looking trends set to emerge in 2026.
Connecting the Middle East and Africa. Step into the vibrant world of trade, agency and project finance at Exile’s (TXF, Proximo and Uxolo) MEA 2026.
View more
Unveil Amsterdam's allure! Elevate your pipeline with top dealmakers. An Industry Awards dinner adds glamour to this unmissable adventure.
View more